Publications
5539 Results
- Journal / Conference
- Proc of the American Society of Clinical Oncology 20:336a(#1340)
- Year
- 2001
- Research Committee(s)
- Lung
- Study Number(s)
- S9714
A phase II Southwest Oncology Group trial (S9714) utilizing paclitaxel by 96-hour infusion in stage IIIb and IV bronchioloalveolar carcinoma of the lung (BAC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 20:224a(#894)
- Year
- 2001
- Research Committee(s)
- Head and Neck
- Study Number(s)
- E1395
Phase III study comparing cisplatin (C) & 5-flurouracil (F) versus cisplatin (C) & paclitaxel (T) in metastatic/recurrent head & neck cancer (MHNC).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 20:2a(#4)
- Year
- 2001
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9201 (RTOG-91-11)
Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R91-11.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 20:282a(#1125)
- Year
- 2001
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9007
Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in myeloid leukemia patients in Southwest Oncology Group (SWOG) trials.
- Journal / Conference
- Journal of Urology 165(5)Suppl:260(#1069)
- Year
- 2001
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
SWOG 8710 (INT-0080): randomized phase III trial of neoadjuvant MVAC + cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 20:329a(#1313)
- Year
- 2001
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9308, SWOG-9509
Should older patients (PTS) receive combination chemotherapy for advanced stage non-small cell lung cancer (NSCLC)? an analysis of Southwest Oncology trials 9509 and 9308.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 20:133a(#527)
- Year
- 2001
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9401 (NCCTG-90-46-52)
Phase III trial of 5-Fluorouracil (5FU), levamisole (LEV), +/- leucovorin (LV) as adjuvant treatment (ADJ) of resected metastatic colorectal cancer (M-CRC) an NCCTG/MD Anderson/SWOG study.
- Journal / Conference
- Gynecologic Oncology 80(2):276-277(#6)
- Year
- 2001
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9318
Recombinant Human Erythropoietin (EPO) as an adjunct to radiation therapy (RT) and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group (SWOG) study
- Journal / Conference
- New England Journal of Medicine 345(10):725-730
- Year
- 2001
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 20:315a(#1255)
- Year
- 2001
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9504